Oppenheimer (OPY) News Today $62.82 -1.91 (-2.95%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$62.86 +0.04 (+0.06%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period HUB Cyber Security Ltd Settles Major Legal Claims, Secures Financial Backing for GrowthFebruary 20 at 5:08 PM | tipranks.comIBM stock: Oppenheimer's deeper look at its valuationFebruary 19 at 9:40 AM | investing.comIs Wall Street Bullish or Bearish on Lululemon Stock?February 19 at 6:04 AM | msn.comInvesco Oppenheimer International Growth Fund Q4 2024 CommentaryFebruary 14, 2025 | seekingalpha.comOppenheimer & Close, LLC Acquires Significant Stake in Capital Properties IncFebruary 13, 2025 | gurufocus.comOppenheimer: International Business Machines (NYSE:IBM) Could Have a Big Run UpFebruary 11, 2025 | tipranks.comAchieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences ConferenceFebruary 11, 2025 | financialpost.comOppenheimer (NYSE:OPY) Stock Price Passes Above Two Hundred Day Moving Average - Here's WhyOppenheimer (NYSE:OPY) Stock Price Passes Above 200 Day Moving Average - Here's WhyFebruary 11, 2025 | marketbeat.comCboe price targets raised at Oppenheimer, Citi after Q4 results, CEO search disclosedFebruary 10, 2025 | seekingalpha.comAmylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 10, 2025 | investing.comInvivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on ...February 10, 2025 | gurufocus.comBe Sure To Check Out Oppenheimer Holdings Inc. (NYSE:OPY) Before It Goes Ex-DividendFebruary 9, 2025 | uk.finance.yahoo.comInsider Sell: Matthew Oppenheimer Sells 29,166 Shares of Remitly Global Inc (RELY)February 7, 2025 | gurufocus.comAmgen Inc (AMGN) to Present at Oppenheimer Healthcare Life Sciences ConferenceFebruary 7, 2025 | gurufocus.comForget saving the planet. Clean energy interests sharpen a different message: Money and jobsSaving the planet is so 2024February 7, 2025 | marketbeat.comAnnovis to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences ConferenceFebruary 7, 2025 | financialpost.comOpthea to Present at Oppenheimer Healthcare ConferenceFebruary 6, 2025 | tipranks.comFulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 6, 2025 | globenewswire.comOppenheimer: Solid Topline Performance And Multiple, But Comp Expense Caps Profit GrowthFebruary 6, 2025 | seekingalpha.comLigand Pharmaceuticals Inc (LGND) to Present at Oppenheimer 35th Annual Healthcare Life ...February 6, 2025 | gurufocus.comInnoviva Inc (INVA) to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 6, 2025 | gurufocus.comCytokinetics Inc (CYTK) Announces CEO's Participation in Oppenheimer Healthcare ConferenceFebruary 5, 2025 | gurufocus.comTerns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | globenewswire.comAdverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | globenewswire.comARS Pharmaceuticals Inc (SPRY) Announces Participation in Oppenheimer 35th Annual Healthcare ...February 5, 2025 | gurufocus.comRhythm Pharmaceuticals Inc (RYTM) Announces Participation in Oppenheimer Healthcare ConferenceFebruary 5, 2025 | gurufocus.comMindMed to Present at Oppenheimer Healthcare ConferenceFebruary 4, 2025 | tipranks.comCardiol Therapeutics to Present at Healthcare Conference, Highlighting Advances in Heart Disease TherapiesFebruary 4, 2025 | tipranks.comenGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | financialpost.comCardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | investing.comNurix Therapeutics Inc (NRIX) to Participate in Oppenheimer Healthcare ConferenceFebruary 4, 2025 | gurufocus.comSatellos Bioscience to Showcase at Oppenheimer Healthcare ConferenceFebruary 4, 2025 | tipranks.comOppenheimer (NYSE:OPY) Stock Rating Lowered by StockNews.comStockNews.com lowered shares of Oppenheimer from a "strong-buy" rating to a "buy" rating in a research report on Monday.February 3, 2025 | marketbeat.com‘An Attractive Setup Into Earnings,’ Says Oppenheimer About Alphabet StockFebruary 3, 2025 | tipranks.comImmuneering Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025February 3, 2025 | quiverquant.comQuarterly results look "promising" despite AI, tariff concerns - OppenheimerFebruary 3, 2025 | investing.comOppenheimer Holdings Reports Record 2024 Financial ResultsFebruary 3, 2025 | tipranks.comVor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences ConferenceFebruary 3, 2025 | investing.comDyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 3, 2025 | gurufocus.comVor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences ConferenceFebruary 3, 2025 | gurufocus.comDyne Therapeutics Inc (DYN) to Present at Oppenheimer Healthcare ConferenceFebruary 3, 2025 | gurufocus.comOppenheimer Holdings Inc. (NYSE:OPY) Declares Quarterly Dividend of $0.18Oppenheimer Holdings Inc. (NYSE:OPY) announced a quarterly dividend on Friday, January 31st. Stockholders of record on Friday, February 14th will be paid a dividend of 0.18 per share by the financial services provider on Friday, February 28th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Friday, February 14th.February 1, 2025 | marketbeat.comOppenheimer (NYSE:OPY) Stock Price Down 4.7% - Time to Sell?Oppenheimer (NYSE:OPY) Stock Price Down 4.7% - Here's What HappenedJanuary 31, 2025 | marketbeat.comOppenheimer (NYSE:OPY) Announces Earnings ResultsOppenheimer (NYSE:OPY - Get Free Report) announced its quarterly earnings data on Friday. The financial services provider reported $0.92 earnings per share for the quarter. Oppenheimer had a net margin of 5.27% and a return on equity of 9.50%.January 31, 2025 | marketbeat.comOppenheimer Holdings Maintains SEC Compliance in Latest FilingJanuary 31, 2025 | tipranks.comOppenheimer Holdings Inc (OPY) Reports Q4 2024 Earnings: EPS at $1.04, Revenue Surges to $375. ...January 31, 2025 | gurufocus.comOppenheimer Holdings Achieves Record Revenue in 2024 Despite Rising ExpensesJanuary 31, 2025 | tipranks.comOppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2024 EarningsJanuary 31, 2025 | prnewswire.comOppenheimer stock soars to all-time high of $73.07January 30, 2025 | msn.comOppenheimer Downgrades Apple (AAPL) Rating Amid Investor CautionJanuary 29, 2025 | gurufocus.com Get Oppenheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for OPY and its competitors with MarketBeat's FREE daily newsletter. Email Address OPY Media Mentions By Week OPY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPY News Sentiment▼0.320.88▲Average Finance News Sentiment OPY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPY Articles This Week▼34▲OPY Articles Average Week Get Oppenheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for OPY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Morgan Stanley News Today The Goldman Sachs Group News Today Charles Schwab News Today Raymond James News Today LPL Financial News Today Stifel Financial News Today Evercore News Today Lazard News Today Piper Sandler Companies News Today BGC Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OPY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oppenheimer Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oppenheimer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPY Stock Alerts